The Handbook of Contraception : (Record no. 102867)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 11357nam a22005293i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC4178311 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240729130127.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2015 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783319201856 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9783319201849 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC4178311 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL4178311 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaPaEBR)ebr11123125 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaONFJC)MIL838308 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)922581469 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RG1-991 |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 613.9/43 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Shoupe, Donna. |
| 245 14 - TITLE STATEMENT | |
| Title | The Handbook of Contraception : |
| Remainder of title | A Guide for Practical Management. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 2nd ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Cham : |
| Name of producer, publisher, distributor, manufacturer | Springer International Publishing AG, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2015. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2016. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (300 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | Current Clinical Practice Series |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Intro -- Dedication -- Series Editor Introduction -- Preface -- Contents -- List of Contributors -- Chapter 1: Contraceptive Effectiveness -- Introduction -- What Is Efficacy Verses Effectiveness? -- Measuring Contraceptive Efficacy -- Efficacy of Current Contraceptive Methods -- No Method -- Female Sterilization -- Male Sterilization -- Intrauterine Device (Paragard/Mirena/Skyla/Liletta) -- Etonogestrel Subdermal Implant (Implanon/Nexplanon) -- Depot Medroxyprogesterone Acetate (DepoProvera) -- Contraceptive Pills, Patches, Rings -- Condoms -- Female Barrier Methods (Diaphragm, Cervical Cap, Contraceptive Sponge) -- Spermicides -- Fertility Awareness Methods -- Withdrawal -- Contraceptive Counseling -- Conclusion -- References -- Chapter 2: Choosing the Right Contraceptive -- General Reproductive Age -- Concerns: Cancer Risk -- Contraceptive Options -- Specific Problems: Acne or Androgen Excess -- Specific Problems: Bleeding Problems -- Specific Problems: Compliance -- Specific Problems: Medical Problems -- Contraceptive Options: IUDs -- Contraceptive Options: Subdermal Implant -- Contraceptive Options: Low-Dose Combination Hormonal Methods: COCs, Vaginal Ring, and Patch -- Contraceptive Options: Depo-Provera (DMPA), Depo-subQ, and Progestin-Only Pill/Mini-Pills -- Contraceptive Options: Barrier Methods -- Contraceptive Options: Emergency Contraception -- Contraceptive Options: Natural Family Planning -- Adolescents -- Counseling the Teenager -- Choosing the Correct Contraceptive Method -- Options for Adolescents: Subdermal Progestin Implant -- Options: Intrauterine Device -- Options: Male and Female Condom -- Options: Oral Contraceptives, Patch, or Ring -- Options: Depo-Provera (DMPA) and Depo-subQ Provera 104™ -- Options: Diaphragm and Cervical Caps or Shields -- Options: Emergency Contraception -- Perimenopausal Women -- Concerns: Cancer Risk. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Concerns: Perimenopausal Bleeding Problems -- Concerns: Perimenopausal Symptoms -- Concerns: Decline of BMD -- Concerns: Cardiovascular Risks -- Concerns: Breast Cancer Risk -- Contraceptive Options -- Contraceptive Options: Sterilization -- Contraceptive Options: Barrier Methods -- Contraceptive Options: IUDs -- Contraceptive Options: Progestin-Only Methods: Depo-Provera (DMPA), Depo-subQ, Mini-Pills, and Implant -- Contraceptive Options: Emergency Contraception -- Contraceptive Options: Natural Family Planning -- Contraceptive Options: Low-Dose Combination Hormonal Methods-OCs and Vaginal Ring -- Patient Screening and Choosing a Combination Hormonal Method for Perimenopausal Women -- Noncontraceptive Benefits of Low-Dose OCs in Perimenopausal Women -- When It Is Safe to Discontinuing OCs or Switch to Hormone Therapy -- Pregnancy and During Lactation -- Timing of Initiation -- Options -- Contraceptive Options: Implant -- Contraceptive Options: IUD -- Contraceptive Options: Barriers -- Contraceptive Options: Tubal Ligation and Fallopian Tube Micro-insert -- References -- Chapter 3: Contraception for Women with Medical Conditions -- Introduction -- Resources -- US Medical Eligibility Criteria for Contraceptive Use (US MEC) -- US Selected Practice Recommendations (SPR) -- Guidelines for Women with Specific Medical Conditions -- Hypertension -- Diabetes -- Lipid Disorders (Hyperlipidemia) -- Obesity -- Headache -- Current or History of Deep Venous Thrombosis (DVT) or Pulmonary Embolism (PE) -- Tobacco Smoking -- HIDS -- Gynecologic Cancers -- Breast Cancer -- Cervical Cancer and Endometrial Cancer -- Ovarian Cancer -- Solid Organ Transplantation -- Conclusions -- References -- Important Resources -- Chapter 4: Combination Oral Contraceptive Pills -- General Overview of Method -- Category Options -- Clinical Effectiveness -- Mechanism of Action. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Eligibility -- Noncontraceptive Health Benefits -- Initiation -- Counseling Tips -- Summary -- References -- Chapter 5: Progestin-Only Oral Contraceptives -- General Overview of the Method -- Category Options -- Picking the Right Candidate -- Good Candidates -- Poor Candidates -- Advantages -- Contraceptive-Linked Benefits -- Non-contraceptive Benefits -- Disadvantages -- Side Effects -- Serious Side Effects -- Warning Signals -- Reproductive Effects -- Drug Interactions -- Precautions/Contraindications [WHO/CDC Recommendations] [1, 10] -- Counseling Tips -- Instructions to Use -- Timing of Initiation -- Managing Side Effects -- Clinical Effectiveness -- Mechanism of Action -- Tips on Cost and Insurance Issues -- References -- Chapter 6: Transdermal Contraceptive Delivery Systems -- General Overview of Method -- Category Options -- Ethinyl Estradiol/Norelgestromin Transdermal System (EE/NGM TDS, Ortho Evra) -- New Options [in Development] -- A New Transdermal Contraceptive Delivery System: Levonorgestrel and Ethinyl Estradiol (Twirla, Agile Therapeutics) -- Gestodene and Ethinyl Estradiol Transdermal System (Bayer Healthcare) -- Transdermal Progestin Delivery Systems for Contraception -- Desogestrel Transdermal System -- AG1000-6.5: Levonorgestrel Transdermal System -- Norethindrone Acetate Transdermal System -- Picking the Right Candidate for a Contraceptive Patch -- Good Candidates -- Poor Candidates -- Advantages -- Contraceptive-Related Benefits for a Transdermal System -- Non-contraceptive-Linked Benefits -- Disadvantages of a Contraceptive Patch -- Side Effects Associated with Transdermal Contraceptive Delivery Systems -- Serious Side Effects Related to a Transdermal Contraceptive Delivery System -- Warning Signals Associated with Serious Adverse Events -- Reproductive Effects -- Drug Interactions -- Contraindications [WHO/CDC Recommendations]. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Absolute Contraindications -- Relative Contraindications -- Counseling Tips -- Instructions to Use -- Timing of Initiation -- Managing Side Effects -- Clinical Effectiveness -- Mechanism of Action -- Tips on Cost and Insurance Issues -- References -- Chapter 7: Contraceptive Ring -- Introduction -- Overview of the Method -- Pharmacokinetics -- Mechanism of Action -- Clinical Effectiveness -- Continuation -- Advantages of the Contraceptive Ring -- Disadvantages of the Contraceptive Ring -- Side Effects -- Venous Thromboembolism -- Arterial Thromboembolism -- Weight Gain -- Hyperlipidemia -- Reproductive Effects -- Cancer Risk -- Contraindications -- Drug Interactions -- Counseling and Patient Selection -- Instructions to Use -- Switching from Another Method -- Starting After Pregnancy -- Counseling Tips -- Poor Candidates -- Summary -- References -- Chapter 8: Progestin Injectable Contraceptives -- General Overview of Method -- Category Options -- Picking the Right Candidate -- Advantages -- Special Issues -- Skeletal Health -- Sexually Transmitted Infection Risk -- Cardiovascular Risk -- Cancer Risk -- Contraindications -- Screening Tests -- Repeat Injections -- Managing Side Effects -- Bleeding -- Weight Gain -- Clinical Effectiveness -- Mechanism of Action -- Tips on Cost and Insurance Issues -- References -- Chapter 9: Implantable Contraception -- Introduction -- History of Implantable Contraception -- Candidates for Implantable Contraception -- Women with Chronic Medical Conditions -- Lactating Women -- Adolescents -- Pharmacology -- Mechanism of Action -- Efficacy -- General Population -- Overweight and Obese Women -- Drug Interactions Impacting Efficacy -- Counseling -- Irregular Bleeding -- Management of Irregular Bleeding -- Other Side Effects -- Sexually Transmitted Infections -- Initiation -- Backup Contraception. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Box 1 How to be reasonably certain that a woman is not pregnant -- Insertion -- Required Equipment for Etonogestrel Implant Insertion -- Positioning the Patient -- Anesthesia -- Insert Implant -- Verify Placement -- Post-insertion Care and Follow-Up -- Complications of Insertion -- Removal -- Procedure -- Difficult Removals -- Imaging Techniques -- Reinsertion -- Jadelle -- Summary -- References -- Chapter 10: Intrauterine Contraception: Comparison of the Copper T Intrauterine Device with the Levonorgestrel Intrauterine Systems -- Category Options -- General Overview of Methods -- Clinical Effectiveness -- Picking the Right Candidate -- Good Candidates for IUC Use -- Especially Good Candidates for copper T IUD -- Especially Good Candidates for LNG-20 IUS -- Special Populations -- Postpartum -- Post-abortion -- Nulliparity -- HIV -- Poor Candidates for IUC Insertion -- Advantages: Contraceptive-Linked Benefits -- IUD as Emergency Contraception -- Non-contraceptive Benefits -- Therapeutic Uses of the LNG-20 -- Heavy Menstrual Bleeding and Bleeding Disorders -- Endometriosis and Pelvic Pain -- Progestin Therapy to Prevent or Treat Endometrial Hyperplasia -- Clinical Concerns -- Fertility Post-IUC -- Ectopic Pregnancy and IUC -- Counseling Tips -- Insertion Tips -- Loading the Device -- Removal Tips -- Managing Side Effects -- Explusion -- Mechanism of Action -- Timing of Initiation -- Tips on Cost and Insurance Issues -- References -- Chapter 11: Barrier Contraceptives -- Summ ary -- Introduction -- Male Condoms -- Efficacy -- Mechanism of Action -- Advantages of Male Condoms -- Disadvantages of Male Condoms -- Special Comments -- Patient Counseling -- Instructions for Correct Condom Use -- Encouraging Developments -- Vaginal Barriers -- Female Condom (FC2) -- Efficacy -- Mechanism of Action -- Advantages of Female Condom (FC2) -- Disadvantages. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Patient Counseling. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Internal medicine. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mishell, Daniel R., Jr. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Shoupe, Donna |
| Title | The Handbook of Contraception |
| Place, publisher, and date of publication | Cham : Springer International Publishing AG,c2015 |
| International Standard Book Number | 9783319201849 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Current Clinical Practice Series |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=4178311">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=4178311</a> |
| Public note | Click to View |
No items available.